跳至主要内容
临床试验/NCT06254508
NCT06254508终止不适用

The Effectiveness of an Online FITT-VP Principle Based Exercise Program and Dietary Guidance in the Management of Childhood and Adolescent Obesity.

Children's Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2024年2月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
33
试验地点
1
主要终点
BMI

研究概览

简要总结

This controlled clinical trial aims to compare the effects of an online program that includes exercise guided by the FITT-VP principle and dietary advice, conducted by fitness coaches, in children and adolescents with obesity with a control group that will be enrolled in conventional in-clinic nutrition and exercise advice. All participants will be monitored for 8 months during the active intervention, and followed by 16 months of observation.

The study will evaluate the following parameters between groups: BMI, anthropometry, blood biochemistry panel (ALT/AST, lipids, uric acid, HOMA-IR, HbA1c), food frequency questionaire, household survey, satisfaction survey, and adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
9 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Simple obesity: Body mass index (BMI) between +2SD and +3SD of the reference range: based on the "Standard Deviation Curve of BMI for Children 0-18 Years of Age in China", which was developed by the Physical Development Survey of Children in Nine Provinces/Cities in 2005;
  • Not participating in other weight management programs currently or in the 3 months prior to the study;
  • Accepts to participate and signs informed consent.

排除标准

  • Currently taking or planning to take medications or interventions that affect body weight during the study period (32 weeks)
  • Obesity caused by other medical conditions. For example, hypothalamic-pituitary disease, hypothyroidism, growth hormone deficiency, Cushing's syndrome, obesity-related syndromes.
  • Comorbidity with other chronic diseases. E.g. psychiatric diseases, respiratory diseases, gastrointestinal diseases, rheumatic diseases, hepatic and renal insufficiency, chronic infectious diseases;
  • Presence of abnormal laboratory values at the time of screening indicating a clinically significant underlying disease or condition that may prevent the subject from participating in the study; or presence of abnormalities in the following laboratory tests: alanine aminotransferase (ALT) greater than 5 times the upper limit of normal, serum creatinine (Scr) greater than 1.5 times the upper limit of normal.
  • Contraindications to physical exercise or exercise-related risks. For example, history of asthma, history of hypoglycemia/diabetes, history of heart disease, history of cardiovascular disease, fracture/surgery/planned surgery within the last 1 year, psychomotor retardation, motor system defects/disabilities, previous history of exercise intolerance;

研究组 & 干预措施

FITT to CON

Active Comparator

Online program that includes exercise guided by the FITT-VP principle and dietary advice for 16 weeks, followed by conventional in-clinic nutrition and exercise advice and self-control for 16 weeks.

干预措施: Online program that includes exercise guided by the FITT-VP principle and dietary advice (Behavioral)

FITT to CON

Active Comparator

Online program that includes exercise guided by the FITT-VP principle and dietary advice for 16 weeks, followed by conventional in-clinic nutrition and exercise advice and self-control for 16 weeks.

干预措施: Conventional in-clinic nutrition and exercise advice and self-control (Behavioral)

CON to FITT

Active Comparator

Conventional in-clinic nutrition and exercise advice and self-control for 16 weeks, followed by online program that includes exercise guided by the FITT-VP principle and dietary advice for 16 weeks.

干预措施: Online program that includes exercise guided by the FITT-VP principle and dietary advice (Behavioral)

CON to FITT

Active Comparator

Conventional in-clinic nutrition and exercise advice and self-control for 16 weeks, followed by online program that includes exercise guided by the FITT-VP principle and dietary advice for 16 weeks.

干预措施: Conventional in-clinic nutrition and exercise advice and self-control (Behavioral)

结局指标

主要结局

BMI

时间窗: 16, 32, 52, 104 weeks

Reduction in body mass index (the body mass \[kg\] divided by the square of the body height \[m\])

次要结局

  • Dietary habits(16, 32, 52, 104 weeks)
  • AE(16, 32, 52, 104 weeks)
  • Tch(16, 32 weeks)
  • LDL-c(16, 32 weeks)
  • Uric acid(16, 32 weeks)
  • HbA1c(16, 32 weeks)
  • HOMA-IR(16, 32 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Feihong Luo

Chief, Department of Endocrinology and Inherited Metabolic Diseases

Children's Hospital of Fudan University

研究点 (1)

Loading locations...

相似试验